COVID 19 antibody test | sciencenewsnet.in

Breaking News

Roy Choi Will Speak to Cal State Fullerton’s Class of 2024

Compact quantum light processing

Researchers develop a new way to safely boost immune cells to fight cancer

Alcohol-Induced Blackouts May Be Linked to How a Person Drinks, Not Just How Much

Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms

American College of Physicians issues clinical recommendations for newer pharmacological treatments of adults with Type 2 diabetes

RCT finds calories may be more important than meal timing when it comes to weight loss

Newer antibiotics underprescribed for highly resistant infections

Chula Ranks No.1 in Thailand for 32 Subjects in the QS World University Rankings by Subject 2024

Researchers to share expertise at international conference on mine water, reclamation

20 Apr, 2024

New study finds reinfection by SARS-CoV-2 in healthy young adults is common

February 1, 2021 sarah JonasResearch Alert

MEDIA ADVISORY Paper title: SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study Corresponding Author: Stuart C. Sealfon, MD, Professor of Neurology, Neuroscience and Pharmacological Sciences, Icahn School of Medicine at Mount Sinai Bottom Line: Although…

Baylor Scott & White Health Enrolls First Patients in the World in Trial for Inhaled Remdesivir

October 2, 2020 sarah JonasFeature

Earlier this month, Baylor Scott & White Research Institute enrolled the first four patients in the world on Gilead’s new clinical trial involving an investigational inhaled solution of remdesivir (NCT04539262). This is Gilead’s first trial in COVID-19 patients examining the safety and efficacy of an inhaled solution of the drug in an outpatient setting. The study of an inhaled solution asks whether this mode of delivery can help reduce the amount of virus from the airways earlier.